Open beta · everything is free with an account while we build. Founding accounts get preferred pricing when paid plans arrive. Create yours →
NM

NATALIE MCINTYRE

Registered · LDAActive

Background

Career
Buda, TX · current
Government experience
Special Assistant to the President
Office of Legislative Affairs; Sen. Bill Hagerty Legislative Director; OMB Deputy Associate Director, Legislative Affairs; ONDCP Senior Policy Advisor and White House Liaison; Sen. McConnell Legislative Assistant.
Covered official positions, as disclosed on federal filings

The past 12 months

Clients
16
past 12 months
Filings
23
past 12 months
Agencies contacted
Executive Office of the President (EOP)SENATEHOUSE OF REPRESENTATIVESDefense, Dept of (DOD)Health & Human Services, Dept of (HHS)Office of Management & Budget (OMB)Treasury, Dept ofCommerce, Dept of (DOC)Education, Dept ofCenters For Medicare and Medicaid Services (CMS)Federal Trade Commission (FTC)Securities & Exchange Commission (SEC)U.S. Immigration & Customs Enforcement (ICE)U.S. Trade Representative (USTR)Veterans Affairs, Dept of (VA)Vice President of the U.S.

Specific issues

Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening; including H.R.842 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act; S.339 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act
Health Issues · 2026 Q1
Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening; including H.R.842 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act; S.339 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act
Medicare/Medicaid · 2026 Q1
Issues relating to rare disease and patient access.
Medical/Disease Research/Clinical Labs · 2026 Q1
General issues related to financial value transparency and gainful employment regulations.
Labor Issues/Antitrust/Workplace · 2026 Q1
General issues related to Medicare coverage.
Medicare/Medicaid · 2026 Q1
Medicare and healthcare policy issues as they relate to drug pricing, CMMI, and Medicare Part D; including rebate system reforms
Medicare/Medicaid · 2026 Q1

Clients

2026 · 1 filing
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 2 filings
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 2 filings
$██,███ / qtrFree in beta

Sources

This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗

Recent filings14
2026 Q1
TIDES MEDICAL
Q1lda.gov →
2026 Q1
FINSECA
Q1lda.gov →
2026 Q1
NORFOLK SOUTHERN CORPORATION
Q1lda.gov →
2026 Q1
BLACKSTONE ADMINISTRATIVE SERVICES PARTNERSHIPS L.P.
Q1lda.gov →
2026 Q1
OCEANS ACQUISITION, INC.
Q1lda.gov →
2026 Q1
NASDAQ, INC.
Q1lda.gov →
2026 Q1
NEPHRON NITRILE LLC (DBA AMERICAN ARMOR GLOVES)
Q1lda.gov →
2026 Q1
GRAIL LLC
Q1lda.gov →
2026 Q1
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Q1lda.gov →
2026 Q1
PAUL, WEISS LLP, ON BEHALF OF AD HOC GROUP OF MAJORITY MEMBER PREPA BONDHOLDERS
Q1lda.gov →
2026 Q1
ULTRAGENYX PHARMACEUTICAL INC.
Q1lda.gov →
2026 Q1
ALTANA TECHNOLOGIES, INC.
Q1lda.gov →
2026 Q1
TRICOCI UNIVERSITY OF BEAUTY CULTURE, LLC
Q1lda.gov →
2026 Q1
OGLE SCHOOL MANAGEMENT, LLC
Q1lda.gov →